← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
STERTZER SIMON H
Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001031689
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 1
- Purchases · 24M
- 6
- Average purchase
- $173.8K
- Median purchase
- $127.0K
- Gross purchase value
- $1.0M
Companies: BioCardia, Inc.
6 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-06-24 | BioCardia, Inc. | BCDA | Director | $103.6K | Open filing |
| 2025-09-23 | BioCardia, Inc. | BCDA | Director | $498.0K | Open filing |
| 2025-07-02 | BioCardia, Inc. | BCDA | Director | $150.4K | Open filing |
| 2025-04-25 | BioCardia, Inc. | BCDA | Director | $200.5K | Open filing |
| 2025-03-07 | BioCardia, Inc. | BCDA | Director | $2.5K | Open filing |
| 2025-03-05 | BioCardia, Inc. | BCDA | Director | $88.1K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 6Developing | 100.0% (6/6) | 83.3% (5/6) | +7.5% | +9.4% | -9.0% |
| 20D | 6Developing | 100.0% (6/6) | 33.3% (2/6) | -6.5% | -5.6% | -14.8% |
| 60D | 6Developing | 100.0% (6/6) | 33.3% (2/6) | -13.8% | -12.4% | -38.7% |
| 120D | 5Developing | 100.0% (5/5) | 0.0% (0/5) | -38.5% | -35.9% | -49.0% |
Research patterns
- First purchase in 12M
- 0/5
- Large purchase ≥ $100k
- 4/6
- Cluster buying · 15D
- 6/6
- Buying the dip
- 6/6
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.